Mechanism-Based Treatment for Neonatal Seizures: Still on the Horizon
- PMID: 33021401
- PMCID: PMC7726728
- DOI: 10.1177/1535759720954253
Mechanism-Based Treatment for Neonatal Seizures: Still on the Horizon
Comment on
-
Neonatal seizures: is a novel, mechanism-based treatment finally on the horizon?Epilepsy Curr. 2006 Jul-Aug;6(4):130-2. doi: 10.1111/j.1535-7511.2006.00121.x. Epilepsy Curr. 2006. PMID: 17260035 Free PMC article. No abstract available.
References
-
- Dzhala VI, Brumback AC, Staley KJ. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2008;63(2):222–235. - PubMed
-
- Kahle KT, Barnett SM, Sassower KC, et al. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol. 2009;24(5):572–576. - PubMed
-
- Pressler RM, Boylan GB, Marlow N, et al. for the NEonatal seizure treatment with Medication Off-patent (NEMO) consortium. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol. 2015;14(5):469–477. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
